<?xml version="1.0" encoding="UTF-8"?>
<p id="Par7">As an inhibitor of CYP3A4 and UGT1A1 and a strong inhibitor of OATP1B1, atazanavir may increase the plasma concentrations of other drugs such as proton-pump inhibitors, antacids, and H2-receptor antagonists. Statins such as simvastatin and atorvastatin are also known as 
 <italic>CYP3A4</italic> isoenzyme substrates [
 <xref ref-type="bibr" rid="CR16">16</xref>].
</p>
